Consequently, we proposed that targeting the broader S1P metabolic pathway, rather than focusing solely on S1PR1 signaling, may offer more effective therapeutic strategies in treating EV-A71-associated encephalitis. The gene discussed is S1PR1; the disease is encephalitis.